CN1454629A - Medicine for clinical hemostasis and preparing method thereof - Google Patents
Medicine for clinical hemostasis and preparing method thereof Download PDFInfo
- Publication number
- CN1454629A CN1454629A CN03114147A CN03114147A CN1454629A CN 1454629 A CN1454629 A CN 1454629A CN 03114147 A CN03114147 A CN 03114147A CN 03114147 A CN03114147 A CN 03114147A CN 1454629 A CN1454629 A CN 1454629A
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- powder
- raw material
- hemostasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of medicine for clinic hemostasis and the manufacturing method. The medicine is made up of ramee, pseudo-ginseng, burnet spider, baichaoshuang and cornu cervi degelatinatum. The medicine can realize quick hemostasis, it can be taken orally or external use. The wound cicatrizes well, the cost is low. It is very convenient.
Description
Affiliated technical field the present invention relates to haemostatic medicament and preparation method thereof
Background technology is hemorrhage, comprises traumatic hemorrhage, and internal hemorrhage (breaking the massive hemorrhage that hepatorrhexis, rupture of spleen cause as esophageal vein) is common clinically.If untimely hemostasis can cause death very soon, how dead because of bleeding too much on the battlefield as massive hemorrhage, many clinically method or injection haemostatic medicaments with ligation, stitching do not have more effective external endo-medicine to carry out the hemostatic precedent as yet.
Summary of the invention the object of the present invention is to provide a kind of can immediately hemostasis the, medicine that has no side effect and preparation method thereof.
The object of the present invention is achieved like this, and medicine of the present invention is made by following raw material in weight portion:
45～55 parts of 90～110 portions of Radix Notoginseng of Boehmeria
22～28 parts of 72～88 parts of Pulvis Fumi Carbonisatuss of Radix Sanguisorbae
27～33 parts of 12 Cornu Cervi Degelatinatums of Aranea
Its preparation method is:
1, chooses the clean medical material of the high-quality that meets state health standards, meeting processing and preparing under the relevant environment of pharmacy hygienic standardization of country;
2, above-mentioned various raw materials are concocted respectively, concocted the oven dry of qualified back, again drying and crushing to 80 order fine powder;
3, the fine powder with above-mentioned various raw materials mixes equably in described ratio, obtains mixture;
4, manufacture method routinely again: powder is sprinkling upon equably locates hemorrhage urgent need on the adhesive tape, or powder keeps, be equipped with internal hemorrhage and take.
Due to damaging, cause dead thin blood vessel injury or artery and vein angiorrhexis to cause more than hemorrhage.This drug invention people studies assiduously through clinical practice for many years, tries to explore, and constantly adjusts pharmaceutical formulation, ratio, develops this medicine finally, and having of this medicine blood is the function of water, anti-inflammation detumescence, and the effect of analgesic hemostatic is a hemostasis good medicine.
This medicine has following characteristics:
1, hemostasis in three minutes, Orally taken and externally has effect same;
2, have no side effect, in clinical use, through observing for many years, hemostasis back wound healing is good;
3, cost is low, and is easy to use.
Case one, Lee, man, 47 years old, Dalian Jin Zhou people from district, on August 7th, 99 subacute gastrorrhagia, invalid through other anthemorrhagic drug therapy, prepare the stomach repairing operation, because of financial difficulties, can not hand over surgery cost, come here to seek medical advice, take styptic powder 10g after, do not have bleeding again, visiting has recovered normal after three days.Followed up a case by regular visits to recurrence after 1 year.
Case two, open * *, man, 23 years old, the Dadong District people of Shenyang City.On March 6th, 98 was caused the damage of left lower limb many places because of traffic accident, haemophilia, and this hemostasis of urgent need adhesive tape sticking, hemostasis there is no pain immediately, and the back healing is good, sequela such as infection do not occur.
Below in conjunction with embodiment the present invention is described in further detail.
The specific embodiment
Embodiment 1: press the column weight amount and take by weighing raw material (unit: gram)
Boehmeria 100 gram Radix Notoginseng 50 grams
Radix Sanguisorbae 80 gram Pulvis Fumi Carbonisatuss 25 grams
12 Cornu Cervi Degelatinatums of Aranea, 30 grams
Its preparation method is as follows:
A. choose meet national standard raw medicinal material as raw material, meeting processing and preparing under the relevant environment of pharmacy sanitary standard of country;
B. above-mentioned various raw materials are concocted respectively, and, be ground into 80 order fine powders then 65-75 ℃ of oven dry;
C. the fine powder with above-mentioned various raw materials mixes equably, obtains mixed powder;
D. more routinely manufacture method mixed powder be sprinkling upon equably do the trauma hemostasis urgent need on the adhesive tape, or powder is kept, be equipped with internal hemorrhage and take.
Embodiment 2: press the column weight amount and take by weighing raw material (unit: gram)
Boehmeria 90 gram Radix Notoginseng 45 grams
Radix Sanguisorbae 72 gram Pulvis Fumi Carbonisatuss 22 grams
12 Cornu Cervi Degelatinatums of Aranea, 27 grams
Its preparation method is as follows:
A. choose meet national standard raw medicinal material as raw material, meeting processing and preparing under the relevant environment of pharmacy sanitary standard of country;
B. above-mentioned various raw materials are concocted respectively, and, be ground into 80 order fine powders then 65-75 ℃ of oven dry;
C. the fine powder with above-mentioned various raw materials mixes equably, obtains mixed powder;
D. more routinely manufacture method mixed powder be sprinkling upon equably do the trauma hemostasis urgent need on the adhesive tape, or powder is kept, be equipped with internal hemorrhage and take.
Embodiment 3: press the column weight amount and take by weighing raw material (unit: gram)
Boehmeria 110 gram Radix Notoginseng 55 grams
Radix Sanguisorbae 88 gram Pulvis Fumi Carbonisatuss 28 grams
12 Cornu Cervi Degelatinatums of Aranea, 33 grams
Its preparation method is as follows:
A. choose meet national standard raw medicinal material as raw material, meeting processing and preparing under the relevant environment of pharmacy sanitary standard of country;
B. above-mentioned various raw materials are concocted respectively, and, be ground into 80 order fine powders then 65-75 ℃ of oven dry;
C. the fine powder with above-mentioned various raw materials mixes equably, obtains mixed powder;
D. more routinely manufacture method mixed powder be sprinkling upon equably do the trauma hemostasis urgent need on the adhesive tape, or powder is kept, be equipped with internal hemorrhage and take.
This medicine uses brief summary:
(1) hemostasis at once, reducing swelling and alleviating pain, according to observing for many years, to internal hemorrhage, external haemorrhage, hemostatic efficiency reaches more than 96% in three minutes.
(2) disposable hemostasis, internal hemorrhage can be taken after 4 hours again and once be carried out the steadiness treatment.
(3) toxic effects is in clinical use, through observing no obvious toxic-side effects for many years.
(4) cost is low, and is easy to use.
Claims (3)
1, a kind ofly be used for clinical hemostatic medicine, it is characterized in that described medicine made by following raw material in weight portion:
Boehmeria 90-110 part Radix Notoginseng 45-55 part
Radix Sanguisorbae 72-88 part Pulvis Fumi Carbonisatus 22-28 part
12 Cornu Cervi Degelatinatum 27-33 of Aranea part
2, according to claim 1ly be used for clinical hemostatic medicine, it is characterized in that described medicine made by following raw material by weight:
50 parts of 100 portions of Radix Notoginseng of Boehmeria
25 parts of 80 parts of Pulvis Fumi Carbonisatuss of Radix Sanguisorbae
30 parts of 12 Cornu Cervi Degelatinatums of Aranea
3, the preparation method of the described medicine of claim 1 is characterized in that may further comprise the steps successively:
A. choose meet national standard raw medicinal material as raw material, meeting processing and preparing under the relevant environment of pharmacy sanitary standard of country;
B. above-mentioned various raw materials are concocted respectively, and, be ground into 80 order fine powders then 65-75 ℃ of oven dry;
C. the fine powder with above-mentioned various raw materials mixes equably in described ratio, obtains mixed powder;
D. more routinely manufacture method mixed powder be sprinkling upon equably do the trauma hemostasis urgent need on the adhesive tape, or powder is kept, be equipped with internal hemorrhage and take.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031141471A CN1178691C (en) | 2003-04-03 | 2003-04-03 | Medicine for clinical hemostasis and preparing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031141471A CN1178691C (en) | 2003-04-03 | 2003-04-03 | Medicine for clinical hemostasis and preparing method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1454629A true CN1454629A (en) | 2003-11-12 |
| CN1178691C CN1178691C (en) | 2004-12-08 |
Family
ID=29260025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031141471A Expired - Fee Related CN1178691C (en) | 2003-04-03 | 2003-04-03 | Medicine for clinical hemostasis and preparing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1178691C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600258A (en) * | 2008-04-27 | 2012-07-25 | 李生 | Qingxin Angong pill for clearing heart fire and stopping uterine bleeding |
| CN105311473A (en) * | 2015-11-27 | 2016-02-10 | 黄凤玲 | Rapid hemostasis drug |
-
2003
- 2003-04-03 CN CNB031141471A patent/CN1178691C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600258A (en) * | 2008-04-27 | 2012-07-25 | 李生 | Qingxin Angong pill for clearing heart fire and stopping uterine bleeding |
| CN105311473A (en) * | 2015-11-27 | 2016-02-10 | 黄凤玲 | Rapid hemostasis drug |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1178691C (en) | 2004-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baghdadi | Riga-Fede disease: report of a case and review | |
| CN1178691C (en) | Medicine for clinical hemostasis and preparing method thereof | |
| CN1857318A (en) | Compound Chinese medicine prepn for fast healing trauma and its preparing method | |
| CN101890181A (en) | Swine fibrin glue powder inhalation and preparation method and application thereof | |
| CN1183950C (en) | Chinese herbal medicine preparation for treating burns | |
| CN1246021C (en) | Non-scar plaster for treating trauma and its preparing process and usage | |
| CN1169561C (en) | Medicine for treating diseases of rectum and anus | |
| CN105030958A (en) | Pharmaceutical composition and application thereof | |
| CN101062054A (en) | Medicine for curing wound | |
| CN1261117C (en) | Medicine for treating bum, empyrosis and bedsore | |
| CN1093923A (en) | Wound, ulcer loose | |
| CN1911231A (en) | Medicine for treating burns | |
| CN110251716B (en) | Gel dressing for wound care and preparation method thereof | |
| RU2288730C2 (en) | Method of treatment of oncogynecological patients and gel for its realization | |
| CN1259052C (en) | Medicinal composition for treating burn and scald and preparing method | |
| CN1242773C (en) | Medicine for treating skin wound and its processing method | |
| Ariawan et al. | Effects of Andrographis paniculata Extract as a Wound Dressing in the Proliferation Phase of Rats Palatal Mucosa Wound Healing | |
| CN1258367C (en) | Medicine for treating trauma | |
| EP1648419A1 (en) | Treatment of lesions of soft tissues | |
| CN1068785C (en) | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer | |
| CN1939470A (en) | Chinese medicinal plaster with analgetic, hemostatic repercussive and sore-arresting functions | |
| CN1899520A (en) | Chinese medicine composition for removing wart nevus | |
| JPH09169655A (en) | Powder for external use for dermatic ulcer | |
| CN1193783C (en) | External used medicine against piles | |
| CN1453002A (en) | Inflammation diminishing and granulation promoting ointment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |